Cargando…
Impact of treatment schedule on the efficacy of cytostatic and immunostimulatory agents
Radiation therapy (RT) and cyclin-dependent kinase 4/6 (CDK4/6) inhibitors mediate poorly overlapping cytostatic and immunostimulatory effects, suggesting that combinatorial regimens may enable supra-additive tumor control. Our preclinical findings demonstrate that administration schedule stands out...
Autores principales: | Petroni, Giulia, Galluzzi, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899633/ https://www.ncbi.nlm.nih.gov/pubmed/33659100 http://dx.doi.org/10.1080/2162402X.2021.1889101 |
Ejemplares similares
-
Immunostimulatory effects of radioimmunotherapy
por: Constanzo, Julie, et al.
Publicado: (2022) -
Trial Watch: Immunostimulatory cytokines
por: Vacchelli, Erika, et al.
Publicado: (2012) -
Trial Watch: Immunostimulatory cytokines
por: Vacchelli, Erika, et al.
Publicado: (2013) -
NK cells beat T cells at early breast cancer control
por: Buque, Aitziber, et al.
Publicado: (2020) -
Intrathecal Chemotherapy: Selection of Cytostatic Agents
por: Hayakawa, T., et al.
Publicado: (1970)